Cargando…
Pulsed field ablation for all types of atrial fibrillation single centre experience with individualized approach and medium-term outcome
FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Pulsed field ablation (PFA) is a promising method to reduce procedure time and improve ablation safety and efficacy in all types of atrial fibrillation (AF). PURPOSE: To present ablation approach and medium-term outcomes of PFA in...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207037/ http://dx.doi.org/10.1093/europace/euad122.189 |
_version_ | 1785046360329814016 |
---|---|
author | Fiala, M Cernosek, M Bulkova, V Bahnik, J Rybka, L Funasako, M Lehar, F Manousek, J Toman, O Kala, P |
author_facet | Fiala, M Cernosek, M Bulkova, V Bahnik, J Rybka, L Funasako, M Lehar, F Manousek, J Toman, O Kala, P |
author_sort | Fiala, M |
collection | PubMed |
description | FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Pulsed field ablation (PFA) is a promising method to reduce procedure time and improve ablation safety and efficacy in all types of atrial fibrillation (AF). PURPOSE: To present ablation approach and medium-term outcomes of PFA in all AF types. METHODS: Between 9/2021-10/2022, PFA using Farawave catheter was performed in 250 patients (63±11 years, 65 females). Patients with paroxysmal AF were basically scheduled for simple pulmonary vein isolation (PVI) (Farawave, ICE), patients with longstanding AF (LSPAF) underwent complex left atrial (LA) PFA (Farawave, CS 10-pole catheter, ICE); ablation extent varied in persistent AF. RESULTS: Paroxysmal AF (n=131; 115 ablated in SR), persistent AF (n=39; 11 ablated in SR), and LSPAF (n=64) were ablated with procedure times 58±20, 105±28, and 116±32 minutes, respectively, and fluoroscopy times 9±5, 14±7, and 17±7 minutes, respectively. Additional 16 patients underwent PFA for atrial tachycardia (AT). Ongoing AF was terminated by PFA in 13/16 (81%), 16/28 (57%), and 23/64 (36%) patients with paroxysmal AF, persistent AF, and LSPAF, respectively. In groups of paroxysmal AF ablated in SR, paroxysmal AF ablated in AF, persistent AF ablated in SR, persistent AF, and LSPAF, simple PVI was performed in 100%, 50%, 73%, 11%, and 0 patients respectively; and freedom from AF/AT was present in 86/99 (87%), 11/14 (79%), 7/10 (70%), 11/12 (92%), and 40/52 (77%) patients, respectively, of total 187 patients with follow-up ≥3 months (≥6 months in 139 patients). In 8 patients with repeat ablation post-PFA for paroxysmal AF (n=4), persistent AF (n=2), LSPAF (n=2), extra-PV AF/AT sources dominated in all groups. Complications included one tamponade with pericardiocentesis, and prolonged ST elevation with negative coronary angiography. CONCLUSION: PFA using Farawave catheter was associated with reduced procedure times and favourable medium-term outcome for all AF types. Early experience specifically suggests improved outcome after extensive LA ablation for persistent AF/LSPAF. |
format | Online Article Text |
id | pubmed-10207037 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-102070372023-05-25 Pulsed field ablation for all types of atrial fibrillation single centre experience with individualized approach and medium-term outcome Fiala, M Cernosek, M Bulkova, V Bahnik, J Rybka, L Funasako, M Lehar, F Manousek, J Toman, O Kala, P Europace 10.4.5 - Rhythm Control, Catheter Ablation FUNDING ACKNOWLEDGEMENTS: Type of funding sources: None. BACKGROUND: Pulsed field ablation (PFA) is a promising method to reduce procedure time and improve ablation safety and efficacy in all types of atrial fibrillation (AF). PURPOSE: To present ablation approach and medium-term outcomes of PFA in all AF types. METHODS: Between 9/2021-10/2022, PFA using Farawave catheter was performed in 250 patients (63±11 years, 65 females). Patients with paroxysmal AF were basically scheduled for simple pulmonary vein isolation (PVI) (Farawave, ICE), patients with longstanding AF (LSPAF) underwent complex left atrial (LA) PFA (Farawave, CS 10-pole catheter, ICE); ablation extent varied in persistent AF. RESULTS: Paroxysmal AF (n=131; 115 ablated in SR), persistent AF (n=39; 11 ablated in SR), and LSPAF (n=64) were ablated with procedure times 58±20, 105±28, and 116±32 minutes, respectively, and fluoroscopy times 9±5, 14±7, and 17±7 minutes, respectively. Additional 16 patients underwent PFA for atrial tachycardia (AT). Ongoing AF was terminated by PFA in 13/16 (81%), 16/28 (57%), and 23/64 (36%) patients with paroxysmal AF, persistent AF, and LSPAF, respectively. In groups of paroxysmal AF ablated in SR, paroxysmal AF ablated in AF, persistent AF ablated in SR, persistent AF, and LSPAF, simple PVI was performed in 100%, 50%, 73%, 11%, and 0 patients respectively; and freedom from AF/AT was present in 86/99 (87%), 11/14 (79%), 7/10 (70%), 11/12 (92%), and 40/52 (77%) patients, respectively, of total 187 patients with follow-up ≥3 months (≥6 months in 139 patients). In 8 patients with repeat ablation post-PFA for paroxysmal AF (n=4), persistent AF (n=2), LSPAF (n=2), extra-PV AF/AT sources dominated in all groups. Complications included one tamponade with pericardiocentesis, and prolonged ST elevation with negative coronary angiography. CONCLUSION: PFA using Farawave catheter was associated with reduced procedure times and favourable medium-term outcome for all AF types. Early experience specifically suggests improved outcome after extensive LA ablation for persistent AF/LSPAF. Oxford University Press 2023-05-24 /pmc/articles/PMC10207037/ http://dx.doi.org/10.1093/europace/euad122.189 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | 10.4.5 - Rhythm Control, Catheter Ablation Fiala, M Cernosek, M Bulkova, V Bahnik, J Rybka, L Funasako, M Lehar, F Manousek, J Toman, O Kala, P Pulsed field ablation for all types of atrial fibrillation single centre experience with individualized approach and medium-term outcome |
title | Pulsed field ablation for all types of atrial fibrillation single centre experience with individualized approach and medium-term outcome |
title_full | Pulsed field ablation for all types of atrial fibrillation single centre experience with individualized approach and medium-term outcome |
title_fullStr | Pulsed field ablation for all types of atrial fibrillation single centre experience with individualized approach and medium-term outcome |
title_full_unstemmed | Pulsed field ablation for all types of atrial fibrillation single centre experience with individualized approach and medium-term outcome |
title_short | Pulsed field ablation for all types of atrial fibrillation single centre experience with individualized approach and medium-term outcome |
title_sort | pulsed field ablation for all types of atrial fibrillation single centre experience with individualized approach and medium-term outcome |
topic | 10.4.5 - Rhythm Control, Catheter Ablation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207037/ http://dx.doi.org/10.1093/europace/euad122.189 |
work_keys_str_mv | AT fialam pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome AT cernosekm pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome AT bulkovav pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome AT bahnikj pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome AT rybkal pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome AT funasakom pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome AT leharf pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome AT manousekj pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome AT tomano pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome AT kalap pulsedfieldablationforalltypesofatrialfibrillationsinglecentreexperiencewithindividualizedapproachandmediumtermoutcome |